Jump to main content
博士論文

Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates nonalcoholic fatty liver disease in Japanese patients with type 2 diabetes mellitus

Icons representing 博士論文

Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, ameliorates nonalcoholic fatty liver disease in Japanese patients with type 2 diabetes mellitus

Call No. (NDL)
UT51-2022-A482
Bibliographic ID of National Diet Library
032501503
Material type
博士論文
Author
Kanako Tashima [著]
Publisher
-
Publication date
[2020]
Material Format
Paper
Capacity, size, etc.
3冊 (副論文・参考論文とも)
Name of awarding university/degree
東京女子医科大学,博士(医学)
View All

Notes on use

Note (General):

博士論文

Search by Bookstore

Bibliographic Record

You can check the details of this material, its authority (keywords that refer to materials on the same subject, author's name, etc.), etc.

Paper

Material Type
博士論文
Author/Editor
Kanako Tashima [著]
Author Heading
田島, 加奈子 タシマ, カナコ
Publication Date
[2020]
Publication Date (W3CDTF)
2020
Extent
3冊 (副論文・参考論文とも)
Alternative Title
SGLT2阻害薬のイプラグリフロジンは日本人2型糖尿病のNAFLDを改善する SGLT2 ソガイヤク ノ イプラグリフロジン ワ ニホンジン 2ガタ トウニョウビョウ ノ NAFLD オ カイゼン スル
Degree grantor/type
東京女子医科大学
Date Granted
令和2年4月24日